Company profile
BIOMARIN PHARMACEUTICAL INC
NASDAQ:BMRNBiotechnology: Pharmaceutical Preparations
Drug pipeline (10)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| ALDURAZYME | approved | — | 0 | — |
| BRINEURA | approved | — | 0 | — |
| KUVAN | approved | — | 14 | approved |
| NAGLAZYME | approved | — | 1 | approved |
| PALYNZIQ | approved | — | 0 | — |
Revenue is the latest quarter the company reported for that product, from SEC filings; a fourth quarter is the year less nine months when no filing states one. Trial counts are of the product's ingredients, deduplicated by trial, so products sharing an ingredient share trials.
Clinical trials (81)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04554940 | phase2 | active_not_recruiting | 2020-10-10 | 2027-12-01 | BioMarin Pharmaceutical | A Clinical Trial to Evaluate Safety of Vosoritide in At-risk Infants With Achondroplasia |
| NCT03583697 | phase2 | completed | 2018-06-13 | 2022-01-26 | BioMarin Pharmaceutical | A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia |
| NCT01275066 | phase3 | completed | 2011-02-01 | 2012-08-01 | BioMarin Pharmaceutical | A Double-Blind Study to Evaluate the Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome) |
| NCT05121376 | phase1_2 | active_not_recruiting | 2022-02-15 | 2028-11-01 | BioMarin Pharmaceutical | A Gene Therapy Study of BMN 331 in Subjects With Hereditary Angioedema |
| NCT00789568 | phase1 | completed | 2008-10-01 | 2009-01-01 | BioMarin Pharmaceutical | A Phase 1 Study to Evaluate Effects of Sapropterin Dihydrochloride on QTc Intervals in Healthy Adult Subjects |
FDA applications (9)
| Application | Approved | Type | Applicant | Products | ||||
|---|---|---|---|---|---|---|---|---|
| BLA 125720 | 2023-06-29 | BLA | BIOMARIN PHARMACEUTICAL INC. | |||||
Loading… | ||||||||
| NDA 214938 | 2021-11-19 | NDA | BIOMARIN PHARMACEUTICAL INC | |||||
Loading… | ||||||||
| BLA 761079 | 2018-05-24 | BLA | BIOMARIN PHARMACEUTICAL INC. | |||||
Loading… | ||||||||
| BLA 761052 | 2017-04-27 | BLA | BIOMARIN PHARMACEUTICAL INC. | |||||
Loading… | ||||||||
| BLA 125460 | 2014-02-14 | BLA | BIOMARIN PHARMACEUTICAL INC. | |||||
Loading… | ||||||||